Surgery of resectable local recurrence following colorectal cancer: Compartmental surgery improves local control
- PMID: 35779039
- DOI: 10.1002/jso.26990
Surgery of resectable local recurrence following colorectal cancer: Compartmental surgery improves local control
Abstract
Background: This study aims to identify prognostic factors and define the best extent of surgery for optimizing treatment of local recurrence (LR) following colorectal cancer (CRC).
Methods: An institutional database of consecutive patients who underwent radical resection (R0/R1) of LR following CRC was analyzed prospectively from 2010 to 2021 at one tertiary cancer center.
Results: In this study, 75 patients were included with LR following CRC and analyzed. Patients were categorized as compartmental resections (CompRe) (n = 47) if all adjacent organs were systematically removed, with or without tumor involvement, or noncompartmental resections (NoCompRe) (n = 28) if only contiguously involved organs were resected. NoCompRe were mainly related to contact between major vessels or bone and the tumor, with only 8/19 (42.1%) resections. Five-year overall survival and locoregional-free survival were 37.5% and 38.8% respectively. Local control was better in the CompRe than the NocompRe group (61.4% vs. 11%; p < 0.01). CompRe (hazard ratio: 2.34 [1.16-4.68]; p = 0.017) and absence of peritoneal metastasis (3.05 [1.03-9.02]; p = 0.044) were the two factors associated with decreased abdominal recurrences in multivariate analysis.
Conclusion: Complete compartmental surgery is safe and improves local control. Optimal LR resection needs to remove all contiguous organs, with or without tumor involvement.
Keywords: colorectal metastasis; compartmental surgery; cytoreductive surgery; local recurrence; peritoneal metastases.
© 2022 Wiley Periodicals LLC.
References
REFERENCES
-
- Elferink MA, Visser O, Wiggers T, et al. Prognostic factors for locoregional recurrences in colon cancer. Ann Surg Oncol. 2012;19:2203-2211.
-
- Conroy T, Bosset J-F, Etienne P-L, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702-715.
-
- Liska D, Stocchi L, Karagkounis G, et al. Incidence, patterns, and predictors of locoregional recurrence in colon cancer. Ann Surg Oncol. 2017;24:1093-1099.
-
- Read TE, Mutch MG, Chang BW, et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon1 1No competing interests declared. J Am Coll Surg. 2002;195:33-40.
-
- Fuzun M, Terzi C, Sokmen S, Unek T, Haciyanli M. Potentially curative resection for locoregional recurrence of colorectal cancer. Surg Today. 2004;34:907-912.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
